SMAD4 and colorectal carcinoma: SMAD4 mutations are an adverse prognostic indicator in CRC in general [80,81,82,83], and decreased SMAD4 protein expression—as an indicator of SMAD4 mutation—has been documented in 6 to 14% of MSI-H CRCs [82,84,85].